# Polaryx Therapeutics, Inc.: Form SCHEDULE 13D, filed Feb 5, 2026

- Company: [Polaryx Therapeutics, Inc.](/companies/plyx.md) (CIK 2075320)
- Form: SCHEDULE 13D
- Filed: 2026-02-05
- Accepted by EDGAR: Feb 5, 2026, 16:05 ET
- Period: not reported
- Accession: 0001213900-26-012759
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/2075320/000121390026012759/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2075320/000121390026012759/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2075320/000121390026012759/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Feb 5, 2026.
Source: SEC EDGAR, the filing index for accession 0001213900-26-012759. Last ingested by Listed: Oct 24, 2026, 15:16 ET. No prices; not investment advice.